Home  |  Investor Relations  |  News  |  Events  |  Clinical Trials  |  Contact Us

Investor Relations — NASDAQ: CYTX

Regenerative medicine holds the potential to transform medicine in the same way that computers changed communication

What's New
Jul 30, 2010 CEO Q2 Letter Cytori to Webcast Second Quarter Financial Results
Jul 29, 2010 CEO Q2 Letter Cytori's PureGraft(TM) System Receives European Approval for Fat Grafting Procedures
Aug 6, 2010 CEO Q2 Letter Cytori Therapeutics 2nd Qtr Results Call
Jun 7, 2010 CEO Q2 Letter Noble Financial 6th Annual Equity Conference
 



Shareholder Briefcase | Investor Kit | News and Event Alerts
Download Library | RSS News Feeds

Blog Blog
Follow us on Twitter Twitter
Events Events

Stock Quote
NASDAQ: CYTX
 $4.69   $0.03
Detailed quote »

Investor Presentation Investor Presentation (.pdf)

CEO Letter CEO Q1 Letter (.pdf)

Investor Fact Sheet Barriers to Entry (.pdf)

Investor & Media Contact:
Tom Baker
Tel: +1.858.875.5258
Email: tbaker@cytoritx.com